A Study to Evaluate the Efficacy Safety and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
The purpose of this study is to evaluate the efficacy, safety, and tolerability of guselkumab in adult participants with moderate to severe hidradenitis suppurativa (HS).
A Phase 2, Multicenter, Randomized ,Placebo-Controlled, Double-Blind, Proof-of-Concept Study to Evaluate Guselkumab for the Treatment of Subjects with Moderate to severe Hidradenitis Suppurativa
- ClinicalTrials.gov Identifier: NCT03628924
- Protocol Number: 2018P000636
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required